drugset / Trial / NCT06968429

Summary

This is a multicentre, randomised, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of oral butylphthalide soft capsules for the prophylactic treatment of migraine in adults.

Timeline

Start
2025-05
Primary completion
2027-12
Completion
2028-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Butylphthalide Small molecule 2 unknown Oral

Indications